by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
In the ever-expanding landscape of peptide research, PE-22-28 occupies a notable position. This 7 amino acids compound has been the subject of numerous studies investigating its role in TREK-1 inhibitor and neurogenesis. This article provides a detailed overview of...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Dihexa, also known as Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide), is a modified hexapeptide peptide that has garnered significant attention in the research community. Studies have explored its potential in Alzheimer research, memory enhancement, and related...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into Semax represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 7 amino acids compound has shown promise in areas ranging from cognitive enhancement to ACTH analog, making it a subject of considerable...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
The scientific community’s interest in Selank (Selank Heptapeptide) has grown steadily over the past decade. Composed of 7 amino acids, this peptide has demonstrated notable effects in preclinical models related to anxiolytic and cognitive enhancement. Here, we...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
PE-22-28 (Spadin Analog PE-22-28) has emerged as one of the most studied peptides in modern biomedical research. With its 7 amino acids structure, this compound has attracted attention from researchers worldwide for its potential roles in neurogenesis and rapid onset....
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
In the ever-expanding landscape of peptide research, Dihexa occupies a notable position. This modified hexapeptide compound has been the subject of numerous studies investigating its role in HGF mimetic and neuroplasticity. This article provides a detailed overview of...
